SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Towards new business models for R&D for novel antibiotics · Study

ReviewTowards new business models for R&D for novel antibiotics

Anthony D. So2011

Review2011

Towards new business models for R&D for novel antibiotics

Anthony D. So · Samir Kumar Brahmachari · I. Chopra · Bernard H. Munos · Carl Nathan · Kevin Outterson +5 more

80 citations·0/0 files stored·Drug Resistance Updates

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Microbial Natural Products and Biosynthesis Antibiotic Use and Resistance

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 80 citations exist upstream.

References

1995Success rates for new drugs entering clinical testing in the United States 2004R&D Costs and Returns by Therapeutic Category

Cited by

2016Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality 2016Research and development of antibiotics: insights from patents and citation network

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2002The pharmaceutical industry as a medicines providerreview · 1 shared reference 2005Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industryarticle · 1 shared reference 2008Performance effects of imitative entryarticle · 1 shared reference 2009Investments in Pharmaceuticals Before and After TRIPSreport · 1 shared reference 2015Mechanisms of Hybrid Governance: Administrative Committees in Non-Equity Alliancesarticle · 1 shared reference 2017Why dual leaders will drive innovation: Resolving the exploration and exploitation dilemma with a conservation of resources solutionarticle · 1 shared reference

Details

Year2011

Typereview

Published2011-03-25

VenueDrug Resistance Updates

ISSN-L1368-7646

Languageen

Citations80

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.drup.2011.01.006

openalex_workW1987601923

Links

Imported from OpenAlex (CC0) — nothing here is generated.